Table of Content

1 Study Coverage
1.1 Prevent Meningitis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Prevent Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Meningococcal A Vaccine
1.2.3 Meningococcal AC Vaccine
1.2.4 Meningococcal B Vaccine (MenB)
1.2.5 Meningococcal Conjugate Vaccine (MenaCWY)
1.3 Market by Application
1.3.1 Global Prevent Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Baby
1.3.3 Child
1.3.4 Teenager
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Prevent Meningitis Vaccine Sales Estimates and Forecasts 2018-2034
2.2 Global Prevent Meningitis Vaccine Revenue by Region
2.2.1 Global Prevent Meningitis Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Prevent Meningitis Vaccine Revenue by Region (2018-2024)
2.2.3 Global Prevent Meningitis Vaccine Revenue by Region (2024-2034)
2.2.4 Global Prevent Meningitis Vaccine Revenue Market Share by Region (2018-2034)
2.3 Global Prevent Meningitis Vaccine Sales Estimates and Forecasts 2018-2034
2.4 Global Prevent Meningitis Vaccine Sales by Region
2.4.1 Global Prevent Meningitis Vaccine Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Prevent Meningitis Vaccine Sales by Region (2018-2024)
2.4.3 Global Prevent Meningitis Vaccine Sales by Region (2024-2034)
2.4.4 Global Prevent Meningitis Vaccine Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Prevent Meningitis Vaccine Sales by Manufacturers
3.1.1 Global Prevent Meningitis Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prevent Meningitis Vaccine in 2022
3.2 Global Prevent Meningitis Vaccine Revenue by Manufacturers
3.2.1 Global Prevent Meningitis Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Prevent Meningitis Vaccine Revenue in 2022
3.3 Global Key Players of Prevent Meningitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Prevent Meningitis Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Prevent Meningitis Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Prevent Meningitis Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Prevent Meningitis Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prevent Meningitis Vaccine Sales by Type
4.1.1 Global Prevent Meningitis Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Prevent Meningitis Vaccine Forecasted Sales by Type (2024-2034)
4.1.3 Global Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Prevent Meningitis Vaccine Revenue by Type
4.2.1 Global Prevent Meningitis Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Prevent Meningitis Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Prevent Meningitis Vaccine Price by Type
4.3.1 Global Prevent Meningitis Vaccine Price by Type (2018-2024)
4.3.2 Global Prevent Meningitis Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Prevent Meningitis Vaccine Sales by Application
5.1.1 Global Prevent Meningitis Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Prevent Meningitis Vaccine Forecasted Sales by Application (2024-2034)
5.1.3 Global Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Prevent Meningitis Vaccine Revenue by Application
5.2.1 Global Prevent Meningitis Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Prevent Meningitis Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Prevent Meningitis Vaccine Price by Application
5.3.1 Global Prevent Meningitis Vaccine Price by Application (2018-2024)
5.3.2 Global Prevent Meningitis Vaccine Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Prevent Meningitis Vaccine Market Size by Type
6.1.1 US & Canada Prevent Meningitis Vaccine Sales by Type (2018-2034)
6.1.2 US & Canada Prevent Meningitis Vaccine Revenue by Type (2018-2034)
6.2 US & Canada Prevent Meningitis Vaccine Market Size by Application
6.2.1 US & Canada Prevent Meningitis Vaccine Sales by Application (2018-2034)
6.2.2 US & Canada Prevent Meningitis Vaccine Revenue by Application (2018-2034)
6.3 US & Canada Prevent Meningitis Vaccine Market Size by Country
6.3.1 US & Canada Prevent Meningitis Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Prevent Meningitis Vaccine Sales by Country (2018-2034)
6.3.3 US & Canada Prevent Meningitis Vaccine Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Prevent Meningitis Vaccine Market Size by Type
7.1.1 Europe Prevent Meningitis Vaccine Sales by Type (2018-2034)
7.1.2 Europe Prevent Meningitis Vaccine Revenue by Type (2018-2034)
7.2 Europe Prevent Meningitis Vaccine Market Size by Application
7.2.1 Europe Prevent Meningitis Vaccine Sales by Application (2018-2034)
7.2.2 Europe Prevent Meningitis Vaccine Revenue by Application (2018-2034)
7.3 Europe Prevent Meningitis Vaccine Market Size by Country
7.3.1 Europe Prevent Meningitis Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Prevent Meningitis Vaccine Sales by Country (2018-2034)
7.3.3 Europe Prevent Meningitis Vaccine Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Prevent Meningitis Vaccine Market Size
8.1.1 China Prevent Meningitis Vaccine Sales (2018-2034)
8.1.2 China Prevent Meningitis Vaccine Revenue (2018-2034)
8.2 China Prevent Meningitis Vaccine Market Size by Application
8.2.1 China Prevent Meningitis Vaccine Sales by Application (2018-2034)
8.2.2 China Prevent Meningitis Vaccine Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Prevent Meningitis Vaccine Market Size by Type
9.1.1 Asia Prevent Meningitis Vaccine Sales by Type (2018-2034)
9.1.2 Asia Prevent Meningitis Vaccine Revenue by Type (2018-2034)
9.2 Asia Prevent Meningitis Vaccine Market Size by Application
9.2.1 Asia Prevent Meningitis Vaccine Sales by Application (2018-2034)
9.2.2 Asia Prevent Meningitis Vaccine Revenue by Application (2018-2034)
9.3 Asia Prevent Meningitis Vaccine Sales by Region
9.3.1 Asia Prevent Meningitis Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Prevent Meningitis Vaccine Revenue by Region (2018-2034)
9.3.3 Asia Prevent Meningitis Vaccine Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Prevent Meningitis Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Prevent Meningitis Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Baxter International
11.5.1 Baxter International Company Information
11.5.2 Baxter International Overview
11.5.3 Baxter International Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Baxter International Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Baxter International Recent Developments
11.6 Sanofi Pasteur
11.6.1 Sanofi Pasteur Company Information
11.6.2 Sanofi Pasteur Overview
11.6.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Pasteur Recent Developments
11.7 CSL Behring
11.7.1 CSL Behring Company Information
11.7.2 CSL Behring Overview
11.7.3 CSL Behring Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 CSL Behring Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CSL Behring Recent Developments
11.8 JN International Medical Corporation
11.8.1 JN International Medical Corporation Company Information
11.8.2 JN International Medical Corporation Overview
11.8.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 JN International Medical Corporation Recent Developments
11.9 Serum Institute of India
11.9.1 Serum Institute of India Company Information
11.9.2 Serum Institute of India Overview
11.9.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Serum Institute of India Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Serum Institute of India Recent Developments
11.10 Bio-Med
11.10.1 Bio-Med Company Information
11.10.2 Bio-Med Overview
11.10.3 Bio-Med Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Bio-Med Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bio-Med Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hualan Bio Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Bio Recent Developments
11.12 Wyeth Pharmaceuticals, Inc
11.12.1 Wyeth Pharmaceuticals, Inc Company Information
11.12.2 Wyeth Pharmaceuticals, Inc Overview
11.12.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Wyeth Pharmaceuticals, Inc Recent Developments
11.13 Walvax
11.13.1 Walvax Company Information
11.13.2 Walvax Overview
11.13.3 Walvax Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Walvax Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Walvax Recent Developments
11.14 Zhejiang Tianyuan
11.14.1 Zhejiang Tianyuan Company Information
11.14.2 Zhejiang Tianyuan Overview
11.14.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zhejiang Tianyuan Recent Developments
11.15 Beijing Tiantan Biological
11.15.1 Beijing Tiantan Biological Company Information
11.15.2 Beijing Tiantan Biological Overview
11.15.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Beijing Tiantan Biological Recent Developments
11.16 China National Biotec Group
11.16.1 China National Biotec Group Company Information
11.16.2 China National Biotec Group Overview
11.16.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 China National Biotec Group Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 China National Biotec Group Recent Developments
11.17 Tianjin CanSino Biotechnology
11.17.1 Tianjin CanSino Biotechnology Company Information
11.17.2 Tianjin CanSino Biotechnology Overview
11.17.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Tianjin CanSino Biotechnology Recent Developments
11.18 Zhifei
11.18.1 Zhifei Company Information
11.18.2 Zhifei Overview
11.18.3 Zhifei Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Zhifei Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Zhifei Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prevent Meningitis Vaccine Industry Chain Analysis
12.2 Prevent Meningitis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prevent Meningitis Vaccine Production Mode & Process
12.4 Prevent Meningitis Vaccine Sales and Marketing
12.4.1 Prevent Meningitis Vaccine Sales Channels
12.4.2 Prevent Meningitis Vaccine Distributors
12.5 Prevent Meningitis Vaccine Customers
13 Market Dynamics
13.1 Prevent Meningitis Vaccine Industry Trends
13.2 Prevent Meningitis Vaccine Market Drivers
13.3 Prevent Meningitis Vaccine Market Challenges
13.4 Prevent Meningitis Vaccine Market Restraints
14 Key Findings in The Global Prevent Meningitis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prevent Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Meningococcal A Vaccine
Table 3. Major Manufacturers of Meningococcal AC Vaccine
Table 4. Major Manufacturers of Meningococcal B Vaccine (MenB)
Table 5. Major Manufacturers of Meningococcal Conjugate Vaccine (MenaCWY)
Table 6. Global Prevent Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Prevent Meningitis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Prevent Meningitis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2018-2024)
Table 11. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2024-2034)
Table 12. Global Prevent Meningitis Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 13. Global Prevent Meningitis Vaccine Sales by Region (2018-2024) & (K Units)
Table 14. Global Prevent Meningitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 15. Global Prevent Meningitis Vaccine Sales Market Share by Region (2018-2024)
Table 16. Global Prevent Meningitis Vaccine Sales Market Share by Region (2024-2034)
Table 17. Global Prevent Meningitis Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Prevent Meningitis Vaccine Sales Share by Manufacturers (2018-2024)
Table 19. Global Prevent Meningitis Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Prevent Meningitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Prevent Meningitis Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Prevent Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Prevent Meningitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prevent Meningitis Vaccine as of 2022)
Table 25. Global Key Manufacturers of Prevent Meningitis Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Prevent Meningitis Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Prevent Meningitis Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prevent Meningitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 30. Global Prevent Meningitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 31. Global Prevent Meningitis Vaccine Sales Share by Type (2018-2024)
Table 32. Global Prevent Meningitis Vaccine Sales Share by Type (2024-2034)
Table 33. Global Prevent Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Prevent Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Prevent Meningitis Vaccine Revenue Share by Type (2018-2024)
Table 36. Global Prevent Meningitis Vaccine Revenue Share by Type (2024-2034)
Table 37. Prevent Meningitis Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Prevent Meningitis Vaccine Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global Prevent Meningitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 40. Global Prevent Meningitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 41. Global Prevent Meningitis Vaccine Sales Share by Application (2018-2024)
Table 42. Global Prevent Meningitis Vaccine Sales Share by Application (2024-2034)
Table 43. Global Prevent Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Prevent Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Prevent Meningitis Vaccine Revenue Share by Application (2018-2024)
Table 46. Global Prevent Meningitis Vaccine Revenue Share by Application (2024-2034)
Table 47. Prevent Meningitis Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Prevent Meningitis Vaccine Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. US & Canada Prevent Meningitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Prevent Meningitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 51. US & Canada Prevent Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Prevent Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 53. US & Canada Prevent Meningitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Prevent Meningitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 55. US & Canada Prevent Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Prevent Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 57. US & Canada Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. US & Canada Prevent Meningitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 60. US & Canada Prevent Meningitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 62. Europe Prevent Meningitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 63. Europe Prevent Meningitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 64. Europe Prevent Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Prevent Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 66. Europe Prevent Meningitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 67. Europe Prevent Meningitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 68. Europe Prevent Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Prevent Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 70. Europe Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 71. Europe Prevent Meningitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 73. Europe Prevent Meningitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 74. Europe Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 75. China Prevent Meningitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 76. China Prevent Meningitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 77. China Prevent Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Prevent Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 79. China Prevent Meningitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 80. China Prevent Meningitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 81. China Prevent Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Prevent Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 83. Asia Prevent Meningitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 84. Asia Prevent Meningitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 85. Asia Prevent Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Prevent Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 87. Asia Prevent Meningitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 88. Asia Prevent Meningitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 89. Asia Prevent Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Prevent Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 91. Asia Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 92. Asia Prevent Meningitis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Prevent Meningitis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 94. Asia Prevent Meningitis Vaccine Sales by Region (2018-2024) & (K Units)
Table 95. Asia Prevent Meningitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 98. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 100. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 104. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 105. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 109. GSK Company Information
Table 110. GSK Description and Major Businesses
Table 111. GSK Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. GSK Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. GSK Recent Developments
Table 114. Pfizer Company Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Pfizer Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Pfizer Recent Developments
Table 119. Merck Company Information
Table 120. Merck Description and Major Businesses
Table 121. Merck Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Merck Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Merck Recent Developments
Table 124. Novartis Company Information
Table 125. Novartis Description and Major Businesses
Table 126. Novartis Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Novartis Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Novartis Recent Developments
Table 129. Baxter International Company Information
Table 130. Baxter International Description and Major Businesses
Table 131. Baxter International Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Baxter International Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Baxter International Recent Developments
Table 134. Sanofi Pasteur Company Information
Table 135. Sanofi Pasteur Description and Major Businesses
Table 136. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Sanofi Pasteur Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Sanofi Pasteur Recent Developments
Table 139. CSL Behring Company Information
Table 140. CSL Behring Description and Major Businesses
Table 141. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. CSL Behring Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. CSL Behring Recent Developments
Table 144. JN International Medical Corporation Company Information
Table 145. JN International Medical Corporation Description and Major Businesses
Table 146. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. JN International Medical Corporation Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. JN International Medical Corporation Recent Developments
Table 149. Serum Institute of India Company Information
Table 150. Serum Institute of India Description and Major Businesses
Table 151. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Serum Institute of India Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Serum Institute of India Recent Developments
Table 154. Bio-Med Company Information
Table 155. Bio-Med Description and Major Businesses
Table 156. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Bio-Med Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Bio-Med Recent Developments
Table 159. Hualan Bio Company Information
Table 160. Hualan Bio Description and Major Businesses
Table 161. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Hualan Bio Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Hualan Bio Recent Developments
Table 164. Wyeth Pharmaceuticals, Inc Company Information
Table 165. Wyeth Pharmaceuticals, Inc Description and Major Businesses
Table 166. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Wyeth Pharmaceuticals, Inc Recent Developments
Table 169. Walvax Company Information
Table 170. Walvax Description and Major Businesses
Table 171. Walvax Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Walvax Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Walvax Recent Developments
Table 174. Zhejiang Tianyuan Company Information
Table 175. Zhejiang Tianyuan Description and Major Businesses
Table 176. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Zhejiang Tianyuan Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Zhejiang Tianyuan Recent Developments
Table 179. Beijing Tiantan Biological Company Information
Table 180. Beijing Tiantan Biological Description and Major Businesses
Table 181. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Beijing Tiantan Biological Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Beijing Tiantan Biological Recent Developments
Table 184. China National Biotec Group Company Information
Table 185. China National Biotec Group Description and Major Businesses
Table 186. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. China National Biotec Group Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. China National Biotec Group Recent Developments
Table 189. Tianjin CanSino Biotechnology Company Information
Table 190. Tianjin CanSino Biotechnology Description and Major Businesses
Table 191. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Tianjin CanSino Biotechnology Recent Developments
Table 194. Zhifei Company Information
Table 195. Zhifei Description and Major Businesses
Table 196. Zhifei Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Zhifei Prevent Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Zhifei Recent Developments
Table 199. Key Raw Materials Lists
Table 200. Raw Materials Key Suppliers Lists
Table 201. Prevent Meningitis Vaccine Distributors List
Table 202. Prevent Meningitis Vaccine Customers List
Table 203. Prevent Meningitis Vaccine Market Trends
Table 204. Prevent Meningitis Vaccine Market Drivers
Table 205. Prevent Meningitis Vaccine Market Challenges
Table 206. Prevent Meningitis Vaccine Market Restraints
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Prevent Meningitis Vaccine Product Picture
Figure 2. Global Prevent Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prevent Meningitis Vaccine Market Share by Type in 2022 & 2034
Figure 4. Meningococcal A Vaccine Product Picture
Figure 5. Meningococcal AC Vaccine Product Picture
Figure 6. Meningococcal B Vaccine (MenB) Product Picture
Figure 7. Meningococcal Conjugate Vaccine (MenaCWY) Product Picture
Figure 8. Global Prevent Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Prevent Meningitis Vaccine Market Share by Application in 2022 & 2034
Figure 10. Baby
Figure 11. Child
Figure 12. Teenager
Figure 13. Others
Figure 14. Prevent Meningitis Vaccine Report Years Considered
Figure 15. Global Prevent Meningitis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Prevent Meningitis Vaccine Revenue 2018-2034 (US$ Million)
Figure 17. Global Prevent Meningitis Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2018-2034)
Figure 19. Global Prevent Meningitis Vaccine Sales 2018-2034 ((K Units)
Figure 20. Global Prevent Meningitis Vaccine Sales Market Share by Region (2018-2034)
Figure 21. US & Canada Prevent Meningitis Vaccine Sales YoY (2018-2034) & (K Units)
Figure 22. US & Canada Prevent Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Prevent Meningitis Vaccine Sales YoY (2018-2034) & (K Units)
Figure 24. Europe Prevent Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Prevent Meningitis Vaccine Sales YoY (2018-2034) & (K Units)
Figure 26. China Prevent Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Asia (excluding China) Prevent Meningitis Vaccine Sales YoY (2018-2034) & (K Units)
Figure 28. Asia (excluding China) Prevent Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Prevent Meningitis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Prevent Meningitis Vaccine in the World: Market Share by Prevent Meningitis Vaccine Revenue in 2022
Figure 33. Global Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
Figure 35. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 36. Global Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
Figure 37. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
Figure 39. US & Canada Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 40. US & Canada Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
Figure 41. US & Canada Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 42. US & Canada Prevent Meningitis Vaccine Revenue Share by Country (2018-2034)
Figure 43. US & Canada Prevent Meningitis Vaccine Sales Share by Country (2018-2034)
Figure 44. U.S. Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
Figure 47. Europe Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 48. Europe Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
Figure 49. Europe Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 50. Europe Prevent Meningitis Vaccine Revenue Share by Country (2018-2034)
Figure 51. Europe Prevent Meningitis Vaccine Sales Share by Country (2018-2034)
Figure 52. Germany Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 53. France Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. China Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
Figure 58. China Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 59. China Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
Figure 60. China Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 61. Asia Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
Figure 62. Asia Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 63. Asia Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
Figure 64. Asia Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 65. Asia Prevent Meningitis Vaccine Revenue Share by Region (2018-2034)
Figure 66. Asia Prevent Meningitis Vaccine Sales Share by Region (2018-2034)
Figure 67. Japan Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 68. South Korea Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 69. China Taiwan Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 70. Southeast Asia Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 71. India Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue Market Share by Type (2018-2034)
Figure 74. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue Market Share by Application (2018-2034)
Figure 76. Middle East, Africa and Latin America Prevent Meningitis Vaccine Revenue Share by Country (2018-2034)
Figure 77. Middle East, Africa and Latin America Prevent Meningitis Vaccine Sales Share by Country (2018-2034)
Figure 78. Brazil Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 79. Mexico Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 80. Turkey Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 81. Israel Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 82. GCC Countries Prevent Meningitis Vaccine Revenue (2018-2034) & (US$ Million)
Figure 83. Prevent Meningitis Vaccine Value Chain
Figure 84. Prevent Meningitis Vaccine Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed